Biopharmaceutical company focused on the formulation and commercialization of innovative therapies using its proprietary hydrogel-based formulation technology.
Location: United States, Massachusetts, Bedford
Employees: 201-500
Total raised: $38M
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Ascension ... | ascensionv... |
| - | SV Health ... | svhealthin... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 29.01.2013 | Series D | $24M | - |
| 03.02.2011 | Series D | $14M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 11.03.2024 | Ocular Therapeutix™ Reports Fourth Quarter and Full Year 202... | - | globenewsw... |
| 05.03.2024 | Ocular Therapeutix™ to Release Fourth Quarter and Full Year ... | - | globenewsw... |
| 23.07.2021 | OCULAR THERAPEUTIX : ANNOUNCES SECOND QUARTER 2021 PRELIMINA... | BEDFORD, Mass. - Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the ... | marketscre... |
| 22.07.2021 | Ocular Therapeutix : trade; Announces Second Quarter 2021 Pr... | Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, deve... | marketscre... |
| 01.03.2021 | Ocular Therapeutix™ Announces First Patient Dosed in Phase 2... | BEDFORD, Mass.--(BUSINESS WIRE)--Mar 1, 2021-- Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharma... | oaoa.com/n... |
| 22.01.2015 | Ocular Therapeutix launches dry-eye trial | Ocular Therapeutix (NSDQ:OCUL) said it enrolled the 1st patient in a Phase II study of its bioresorb... | massdevice... |
| 17.07.2014 | Ocular Therapeutix looks to raise $80M in IPO | Medtech Wall... | Ocular Therapeutix sets terms for IPO July 11, 2014 by Brad Perriello Ocular Therapeutix is looking ... | massdevice... |
| 10.06.2013 | Ocular Therapeutix Secures Additional financing in Series D ... | Ocular Therapeutix, a Bedford, MA-based developer of ophthalmic therapeutic products, secured additi... | finsmes.co... |
| 29.01.2013 | Ocular Therapeutix Closes $23.8M Series D Financing | Ocular Therapeutix, a Bedford, MA-based company that develops and commercializes ophthalmic therapeu... | finsmes.co... |
| 28.01.2013 | Ocular Therapeutix eyes a $24M Series D extension | Wall Str... | Ocular Therapeutix said it closed a $23.8 million Series D extension round from existing backers for... | massdevice... |
Show more